Claret Medical Overview

  • Founded
  • 2009
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 120
Employees
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $270M
Latest Deal Amount

Claret Medical General Information

Description

Developer of a cerebral protection system designed to reduce the risk of stroke during transcatheter aortic valve replacement (TAVR). The company's cerebral protection system offers endovascular technology and cerebral vascular-protection systems for transcatheter aortic valve implantation and surgical aortic valve replacement, enabling medical institutes to capture and remove debris dislodged during TAVR procedures, preventing it from traveling to the brain where it may cause injury.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Surgical Devices
Parent Company
Boston Scientific
Primary Office
  • 1745 Copperhill Parkway
  • Suite 1
  • Santa Rosa, CA 95403
  • United States
+1 (707) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Claret Medical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 02-Aug-2018 $270M 0000 00000 Completed Generating Revenue
6. Later Stage VC (Series C) 01-Oct-2017 000.00 0000 000.00 Completed Generating Revenue
5. Early Stage VC (Series B2) 03-Jun-2016 000 000.00 000.00 Completed Generating Revenue
4. Debt - General 03-Mar-2016 00.00 000.00 Completed Generating Revenue
3. Early Stage VC (Series B) 01-Apr-2015 000.00 000.00 000.00 Completed Generating Revenue
2. Early Stage VC (Series A) 24-Aug-2011 $4.33M $4.33M 000.00 Completed Startup
1. Corporate 01-Jan-2009 Completed Startup
To view Claret Medical’s complete valuation and funding history, request access »

Claret Medical Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C 00,000,000 00.000000 00 00.00 00.00 00 00.00 000
Series B-2 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series B-1 20,271,214 $0.000010 8% $0.39 $0.39 1x $0.33 13.46%
Series A 4,779,181 $0.000010 8% $1 $1 1x $0.33 8.24%
To view Claret Medical’s complete cap table history, request access »

Claret Medical Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a cerebral protection system designed to reduce the risk of stroke during transcatheter aortic valve replac
Surgical Devices
Santa Rosa, CA
120 As of 2018
0000
0000 0000-00-00
000000&0 0000

00000000

m ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat
00000000 0000000
Santa Cruz, CA
0 As of 0000
0000
00000000000 0000

00000000

it, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis
00000000 0000000
Irvine, CA
000 As of 0000
00000
0000000 0000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Claret Medical Competitors (8)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Emboline Venture Capital-Backed Santa Cruz, CA 0 0000 00000000000 0000
000000000 00000000 Private Equity-Backed Irvine, CA 000 00000 0000000 0000 00000
000 0000000 Corporate Backed or Acquired Maple Grove, MN 00 000000&0
0000000000 0000000 Venture Capital-Backed Grand Rapids, MI 000.00 0000000000 0 000.00
0000000000 0000000 Pending Transaction (VC) Denver, CO 0 000.00 000000 0
You’re viewing 5 of 8 competitors. Get the full list »

Claret Medical Executive Team (14)

Name Title Board Seat Contact Info
Azin Parhizgar Ph.D Chief Executive Officer, President and Board Member
Rob Weathers Director Of Quality
James Hallums Chief Commercial Officer
George Colindres Assistant Secretary
Brian Cleary Vice President, Clinical and Regulatory Affairs
You’re viewing 5 of 14 executive team members. Get the full list »

Claret Medical Board Members (8)

Name Representing Role Since
Azin Parhizgar Ph.D Claret Medical Chief Executive Officer, President and Board Member 000 0000
Leo Hopkins III Self Board Member 000 0000
You’re viewing 2 of 8 board members. Get the full list »

Claret Medical Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Claret Medical Former Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Easton Capital Investment Group Venture Capital Minority 000 0000 000000 0
Gore Range Capital Venture Capital Minority 000 0000 000000 0
HealthCor Partners Management Growth/Expansion Minority 000 0000 000000 0
Incept VC-Backed Company Minority 000 0000 000000 0
Lightstone Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »